Giant prolactinomas in men: efficacy of cabergoline treatment

Summary objective The term ‘giant prolactinoma’ can be used for tumours larger than 4 cm in diameter and/or with massive extrasellar extension. Cabergoline (CAB), a long‐lasting dopamine agonist (DA), safe and well tolerated, is effective in normalizing PRL levels and inducing tumour shrinkage in mi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical endocrinology (Oxford) 2003-05, Vol.58 (5), p.662-670
Hauptverfasser:	Corsello, S. M., Ubertini, G., Altomare, M., Lovicu, R. M., Migneco, M. G., Rota, C. A., Colosimo, C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Glands - drug effects Adult Aged Antineoplastic Agents - therapeutic use Biological and medical sciences Cabergoline Endocrinopathies Erectile Dysfunction - drug therapy Ergolines - therapeutic use Hormones. Endocrine system Humans Hypothalamus. Hypophysis. Epiphysis (diseases) Hypothyroidism - drug therapy Hypothyroidism - etiology Libido - drug effects Magnetic Resonance Imaging - methods Male Medical sciences Middle Aged Non tumoral diseases. Target tissue resistance. Benign neoplasms Pharmacology. Drug treatments Pituitary Gland - physiopathology Pituitary Neoplasms - complications Pituitary Neoplasms - drug therapy Pituitary Neoplasms - pathology Prolactin - blood Prolactinoma - complications Prolactinoma - drug therapy Prolactinoma - pathology Vision Disorders - complications Vision Disorders - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!